Klotho Neurosciences Enters Material Definitive Agreement
Ticker: GRMLW · Form: 8-K · Filed: Jun 10, 2025 · CIK: 1907223
Sentiment: neutral
Topics: material-definitive-agreement, corporate-actions, equity-securities
Related Tickers: KLTO
TL;DR
Klotho Neurosciences (KLTO) signed a big deal on 6/5/25. Details to follow.
AI Summary
Klotho Neurosciences, Inc. announced on June 5, 2025, that it entered into a Material Definitive Agreement. The company, formerly known as Redwoods Acquisition Corp. and ANEW Medical, Inc., is involved in biological products. This filing also covers unregistered sales of equity securities and Regulation FD disclosures.
Why It Matters
This filing indicates a significant new agreement for Klotho Neurosciences, which could impact its business operations and future financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks and opportunities, the specifics of which are not fully detailed in this initial 8-K filing.
Key Players & Entities
- Klotho Neurosciences, Inc. (company) — Registrant
- Redwoods Acquisition Corp. (company) — Former company name
- ANEW Medical, Inc. (company) — Former company name
- June 5, 2025 (date) — Date of earliest event reported
FAQ
What is the nature of the Material Definitive Agreement entered into by Klotho Neurosciences, Inc.?
The filing states that Klotho Neurosciences, Inc. entered into a Material Definitive Agreement on June 5, 2025, but the specific details of the agreement are not provided in this initial 8-K filing.
When was Klotho Neurosciences, Inc. formerly known as Redwoods Acquisition Corp. and ANEW Medical, Inc.?
Klotho Neurosciences, Inc. was formerly known as ANEW Medical, Inc. after a name change on June 24, 2024, and prior to that, it was formerly known as Redwoods Acquisition Corp. after a name change on January 27, 2022.
What is the SIC code for Klotho Neurosciences, Inc.?
The Standard Industrial Classification (SIC) code for Klotho Neurosciences, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
What other items are reported in this 8-K filing besides the Material Definitive Agreement?
This 8-K filing also reports on Unregistered Sales of Equity Securities, Regulation FD Disclosure, and Financial Statements and Exhibits.
Where is Klotho Neurosciences, Inc. incorporated and what is its business address?
Klotho Neurosciences, Inc. is incorporated in Delaware and its business address is 1115 Broadway, 12th Floor, New York, NY 10010.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 10, 2025 regarding Klotho Neurosciences, Inc. (GRMLW).